PLEIOTROPIC DRUG TRANSPORTERS in Fungi Andr Goffeau, Bruxelles, - - PowerPoint PPT Presentation
PLEIOTROPIC DRUG TRANSPORTERS in Fungi Andr Goffeau, Bruxelles, - - PowerPoint PPT Presentation
PLEIOTROPIC DRUG TRANSPORTERS in Fungi Andr Goffeau, Bruxelles, 2012 PDR RANK & BECH-HANSEN MGG 1973 PDR1 BALZI, CHEN ULASZEWSKI, BOUTRY, DI PIETRO JBC 1987 PDR5 GOLIN 1992 PDR5 BALZI et al , JBC 1994 ASYMETRIC NBDs
PDR RANK & BECH-HANSEN MGG 1973
PDR1 BALZI, CHEN ULASZEWSKI, BOUTRY, DI PIETRO
JBC 1987
PDR5
GOLIN 1992
PDR5
BALZI et al, JBC 1994
Walker A Linker region Walker B
SGGQKQRIAIA GNSGCGKST
ASYMETRIC NBD’s in Pdr5p
LLLDE
NBD2 NBD1
GRPGSGCTT * * * QCWDN * SGGERKRVSIA *** *** **
Yor1 Yor1 Bpt1 Bat1 Yhl035 Yhl035 Ycf1 Ycf1 Ste6 Ynr070 Yor011 Pdr11 Pdr11 Ykr103/4 Yol075 Pdr12 Snq2 Snq2 Pdr10 Pdr10 Pdr15 Pdr15 Pdr5 Pdr5
MULTIPLE disruptions SINGLE disruptions
PDR5 PDR5 -
- like
like NEW NEW MDR MDR
- like
like MRP MRP -
- like
like (NBF-TM)2 (TM-NBF)2
The 16 "full - size" ABC transporters
Bat1 Ste6 Ynr070
MULTIPLE disruptions MULTIPLE disruptions SINGLE disruptions
PDR5 PDR5 -
- like
like NEW NEW MDR MDR -
- like
like MRP MRP -
- like
like (NBF-TM)2 (TM-NBF)2
NO disruptions yet
The 16 "full - size" ABC transporters
Yor011 Yhl035 Yhl035 Pdr12 Pdr10 Pdr10 Yol075 Pdr11 Pdr11 Snq2 Snq2 Pdr15 Pdr15 Pdr5 Pdr5 Yor1 Yor1 Ykr103/4 Bpt1 Ycf1 Ycf1 Ste6
ATP
PDR-like: Pdr5p MRP/MDR-like: Yor1p
ATP ATP ATP
pdr1-3
CARVAJAL et al MGG 1997
The pdr1 The pdr1-
- 3
3 mutant mutant overexpresses
- verexpresses
a new protein band in the plasma membrane a new protein band in the plasma membrane
Decottignies et al , 1997
160kDa Pma
GENETIC PURIFICATI GENETIC PURIFICATION ON
Snq2p Snq2p Pdr5p Pdr5p Yor1p Yor1p Δpdr5 Δ snq2 Δ pdr5,Δ snq2
160 kDa
Pma1p
Decottignies et al., 1997
The mutant The mutant pdr1 pdr1-
- 3
3 in the in the regulatory regulatory gene gene PDR PDR1 1 activates activates expression of expression of several several ABC ABC transporters transporters
PDR1 PDR5 SNQ2 YOR1 Others ?
Elements of the Elements of the PDR Network PDR Network responsive responsive to the to the pdr1 pdr1-
- 3
3 Transcription Transcription Regulator Regulator De RISI et al, De RISI et al, 2002 2002
> >
GENE TARGETS OVEREXPRESSED GENE TARGETS OVEREXPRESSED BY THE pdr1 BY THE pdr1-
- 3 DRUG
3 DRUG-
- RESISTANCE REGULATORY MUTATION
RESISTANCE REGULATORY MUTATION
- 1. ABC
- 2. MFS
- 3. LIPIDS
- 4. WALLS
- 5. STRESS
- 6. UNKNOWN
PDR5 / SNQ2 / YOR1 / PDR10/ PDR15 TPO1 / RTA1 / YOR049c PDR16 / IPT1 / YLR099c YPL088w / YGL028c / YLR413w / YNR067c YLR346c / YGR035c / COS1
De Risi, van den Hazel et al., 1999
GRE2 / MET17 / FRE4 / REV1 / YGR243w
PDR3/YAP1/YRR1
- JULIUS SUBIC
- CLAUDE JACQ
- BERNARD TURCOTTE
PDR Network
- C. Jacq -
- F. Devaux –
E.N.S
TRANSPORT SPECIFICITY
- f Pdr5p
Kolaszkowski et al JBC 1996
PDR5 PDR5 Δ
Antibiotics
chloramphenicol tetracycline anisomycin antimycin A1 cycloheximide lincomycin
- ligomycin
tunicamycin thiolutin
Steroids and their structural analogues
5 β androstan 3 α
- l
17 one 5 β androstan 3 β
- l
17 one 5 β androstan 17β
- l
3 one 5 α androstane 3,17 dione 5 β androstane 3,17 dione 1,4 androstadiene 3,17 dione 5 β pregnan 3 β ol 20 one 4 pregnen 20 α ol 3 one trans dehydroandrosterone 4 androstene 3,17 dione epiandrosterone acetate epiandrosterone estriol 16, 17 diacetate 17 α ethynyl estradiol deoxycorticosterone pregnenolone progesterone testosterone diethylstilbestrol hexestrol 4 hydroxytamoxifen
Ionophores
valinomycin nigericin monensin A23187
Others
2,3,5 triphenyltetrazoliumchloride 4 nitroquinoline n oxide 8 hydroxyquinoline diphenylamine p aminodiphenylamine n decylamine 4 nitrophenol aniline anthron tetranitrotetrazoliumchloride blue resazurine sporidesmin staurosporine fluphenazine cerulenin compactin
Anticancer drugs chemosensitizers
tamoxifen daunorubicin doxorubicin trifluoperazine
Detergents
tetradecyltrimethyl-
- ammonium bromide
hexadecyltrimethyl-
- ammoniumbromide
zwittergent 3-10 zwittergent 3-12 zwittergent 3-14 brij 58 brij 35 n octylglucoside n dodecylglucoside n dodecylmaltoside
Fungicides
itraconazole ketoconazole econazole miconazole triadimenol bitertanol nuarimol fenarimol carbendazim diclobutrazol phenapronil chlorothalonil cyprodinil dodine imazalil prochloraz azoxystrobin flusilazol tebuconazole CGA64251 2 mercapto-
- benzothiazole
krezoxim methyl nystatin soraphen A epoxiconazole
Herbicides
sulfomethuron methyl fluometuron chloroxuron difenoxuron chlorbromuron diuron
Fluorescent dyes
rhodamine 6G rhodamine 123
THE YEAST ABC TRANSPORTER PDR5 MEDIATES RESISTANCE TO MANY DIFFERENT COMPOUNDS
Kolaczkowski et al., 1997
Membranes with Membranes with overexpressed
- verexpressed
Pdr5p Pdr5p show ATP show ATP-
- dependent
dependent fluorescence quenching of fluorescence quenching of Rhodamine Rhodamine 6G 6G
GWENAELLE CONSEIL,2003 GWENAELLE CONSEIL,2003
fluorescence intensity
time [min]
8 6 4 2
PDR5 deleted
ATP
PDR5 overexpressed
- ligomycin
10 20 30
Kolaczkowski et al., 1997
Competitive Competitive inhibition of inhibition of prenyl prenyl-
- flavonoids
flavonoids
- n rhodamine 6G
- n rhodamine 6G
interaction interaction
Ki (chrysin) = 2.7 µM Ki (galangin) = 1.1 µM Ki (6,6-DMA-galangin) = 0.18 µM
Partial and non Partial and non competitive competitive inhibition of the inhibition of the nucleotide nucleotide hydrolytic hydrolytic activity activity
- f
- f
Pdr5p Pdr5p-
- enriched
enriched yeast yeast plasma membranes plasma membranes
Chrysin derivatives
Ki (6-DMA-galangin = 5.4 µM Ki (6-DMA-galangin = 62 µM
HETEROLOGOUS EXPRESSION OF MEMBRANE PROTEINS A.DECOTTIGNIES/B.MONK
MULTIPLE DELETIONS OF YEAST MULTIPLE DELETIONS OF YEAST ABC TRANSPORTERS AND REGULATORS ABC TRANSPORTERS AND REGULATORS
AD123456789 AD123456789
Δ YOR1 Δ PDR15 Δ PDR1 Δ PDR3 Δ PDR11 Δ YCF1 Δ PDR10 Δ PDR5 Δ SNQ2
AD12345678 AD12345678 AD1234567 AD1234567 AD123456 AD123456 AD12346 AD12346 AD1234 AD1234 AD123 AD123 AD12 AD12 AD1 AD1
pdr1-3
HYPERSENSITIVITY TO DRUGS OF THE YEAST STRAIN AD1 HYPERSENSITIVITY TO DRUGS OF THE YEAST STRAIN AD1-
- 9,
9, DELETED OF MULTIPLE ABC TRANSPORTERS DELETED OF MULTIPLE ABC TRANSPORTERS
INHIBITOR INHIBITOR WILD WILD-
- TYPE
TYPE AD1 AD1-
- 9
9 Fold-
MIC ( MIC (µ µg/ml) MIC ( g/ml) MIC (µ µg/ml) g/ml) Difference
Brefeldin A 100 6.25 16 Clotrimazole 1.56 0.0012 128 128 Crystal Violet 0.073 0.049 1.5 Cycloheximide 0.049 0.012 4.1 Fluconazole 12.5 0.391 32 Fluphenazine 12.5 6.25 2 8-Hydroxyquinoline 25 6.25 4 Imazalil 0.78 0.025 31 Ketokonazole 0.781 0.006 130 130 Miconazole 0.391 0.0031 126 126 Nocodazole 6.25 0.781 8 Propiconazole 1.56 0.003 5.2 Rhodamine 6G 25 0.098 255 255 Sanguinarine 3.13 0.781 4 Staurosporine 0.781 0.024 33 Sulfometuron methyl 6.25 1.56 4 Thiabendazole >100 14 7.2
STRAINS made by Anabelle Decottignies and Elvira Carvajal STRAINS curated by Stan Ulaszewski and Michel Ghislain michel.ghislain@uclouvain.bee
Yor1p
Pma1
PDR5p
pdr1-3
YEAST PDR AS A SYSTEM FOR YEAST PDR AS A SYSTEM FOR OVEREXPRESSION OF MEMBRANE PROTEINS OVEREXPRESSION OF MEMBRANE PROTEINS
- Regulatory
pdr1 mutant
- Membrane protein
gene under PDR5 promoter
- Host deleted of major contaminant
ABC transporter genes (PDR5, SNQ2, YOR1, PDR11) YOR1
Decottignies et al., 1997
Decottignies et al., 1997
Pma1p
Yor1p
Δ ABC
pdr1-3 pdr1-3 YOR1 PDR5 pr::YOR1
OVERPRODUCTION OF YOR1p OVERPRODUCTION OF YOR1p
OLIGOMYCIN RESISTANCE
0.1
4 30 µg/ml
MEMBRANE TRANSPORTERS OVEREXPRESSED IN S.CEREVISIAE
- CaCDR1p
- CaCDR2p
- CgCDR1p
- CgCDR2p
- ABCA1
- BenRp
ABC MFS
SUPER CDR1 and Super PDR5 SUPER CDR1 and Super PDR5
in in S.cerevisiae S.cerevisiae plasma membranes plasma membranes
MULTIDELETIONS MULTIDELETIONS SUPER CDR1 SUPER CDR1 SUPER PDR5 SUPER PDR5
B.MONK 2001
EM structural analysis
- f the S.cerevisiae
Pdr5p
MARCO/RIGAUD
PURIFIED Pdr5p PARTICLES
Pdr5p Particles Projection
50 Å
A B A B A B A B
Dimeric Pdr5p
ATP binding requires two « head to tail » subunits
A B B A C C A B B A C C
subunit 1 subunit 2
Walker motifs
Pgp structure, Chang et al ,2009
PHYLOGENY
0.1
YALI005PDR YALI019PDR YALI007PDR YALI009PDR NCU05591.2 KLLA011PDR ASGO002PDR ASGO012PDR DEHA007PDR DEHA017PDR DEHA018PDR DEHA019PDR DEHA013PDR DEHA024PDR DEHA025PDR KLLA017PDR PDR10 CAGL017PDR PDR5 CAGL009PDR PDR15 SCPO012YNR SCPO006YNR NCU09830.2 NCU08056.2 NCU10009.2 YALI024PDR KLLA004PDR CAGL019PDR PDR12 DEHA001PDR ASGO001PDR KLLA010PDR YNR070W CAGL011PDR SNQ2
Neurospora crassa Schizo pombe Yarrowia lipolytica Debaryomyces hansenii Ashbya gossypii Kluyveromyces lactis Candida glabrata Saccharomyces cerevisiae
Neurospora S Pombe SNQ2 PDR5
Conclusion We can now envisage
- crystallization
- f each
catalytic step
- f Pdr5p
- verexpression, purification, crystallization
and phenotypic caracterization
- f each
subfamily
- f
fungal and plant’s Pdr
LYON
- DI PIETRO attilio
- JAULT jean-michel
OTAGO
- MONK brian
- CANNON richard
- NIMMI kyoko
WROCLAW
- ULASZEWSKI stan
LLN/GENA/GENE
- BARET philippe
- DE HERTOG benoit
- DIFFELS julie
- HANCY frederic
PARIS ENS
- JACQ
claude
- MARC philippe
- DEVAUX frédéric
IOWA
- MOYE-ROWLEY
scott
ODENSE
- FEY stephen
- MOSE LARSEN peter
- NAWROCKI arkadiusz
PARIS Curie
- RIGAUD jean-louis
- MARCO sergio
COLLABORATING LABORATORIES
STILL GOING ON
Degradation
- f Pdr5p by GHISLAIN michel
Control by kinases and phosphatase by MONTERO monica Crystallisation
- f Pdr5p by XIA di
Plant Inhibitors
- f Pdr5p by PEIRERA antonio
Crystallisation
- f Yor1p by Falson
pierre Vmr1p a novel vacuolar yeast MRP1 by WAWRZYCKA donata Plant PDRs by BOUTRY marc et al